Hepatitis C and liver transplantation.

Area of Science:

• Hepatology
• Transplant Surgery
• Virology

Background:

• Liver transplantation is a critical treatment for end-stage liver disease, portal hypertension, and liver cancer.
• Despite advances, organ scarcity and recurrent hepatitis C infection post-transplant remain significant issues.
• Recurrent hepatitis C can accelerate graft cirrhosis, leading to graft loss and retransplantation.

Purpose of the Study:

• To highlight the challenges in liver transplantation, particularly concerning organ supply and hepatitis C recurrence.
• To emphasize the need for optimized candidate selection and timing of liver transplants.
• To underscore the importance of enhanced pre- and post-transplant antiviral strategies.

Main Methods:

• Review of current liver transplantation practices and outcomes.
• Analysis of factors contributing to graft loss, including hepatitis C recurrence.
• Evaluation of existing and potential antiviral therapies.

Main Results:

• Organ demand significantly exceeds the available supply for liver transplantation.
• Hepatitis C recurrence is a common cause of graft failure and necessitates retransplantation.
• Current antiviral therapies and immunosuppression have limitations in preventing recurrence and progression.

Conclusions:

• Liver transplantation outcomes can be improved through careful patient selection and optimized transplant timing.
• Enhanced pre- and post-transplant antiviral management is essential to combat hepatitis C recurrence.
• Further research into novel antiviral strategies is needed to improve long-term graft survival.